What is the recommended dosage of Aklief (trifarotene) for acne treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aklief (Trifarotene) Dosage for Acne Treatment

Apply a thin layer of Aklief Cream 0.005% once daily in the evening to clean, dry skin on affected areas. 1

Specific Application Instructions

Dosing by Body Area

  • Face (forehead, cheeks, nose, chin): One pump actuation 1
  • Upper trunk (reachable upper back, shoulders, chest): Two pump actuations 1
  • Middle and lower back: One additional pump actuation if acne is present 1

Application Technique

  • Apply to the entire affected area, not just individual lesions 1
  • Use on clean and dry skin 1
  • Apply in the evening only 1
  • Avoid contact with eyes, lips, paranasal creases, and all mucous membranes 1

Essential Adjunctive Care

Moisturizer Use

  • Use moisturizer as frequently as needed from treatment initiation 1
  • This helps manage the expected dryness and irritation associated with retinoid therapy 1

Safety Considerations

Route of Administration

  • Topical use only - not for oral, ophthalmic, or intravaginal use 1

Age Restrictions

  • Approved for patients 9 years of age and older 2

Expected Adverse Effects

  • Most common: pruritus, irritation, and sunburn 3
  • These are typical retinoid-class effects and generally manageable with proper moisturization 3

Clinical Efficacy Data

Treatment Success Rates

  • Facial acne: 65.1% achieved treatment success (no or almost no acne) at 52 weeks 3
  • Truncal acne: 66.9% achieved treatment success at 52 weeks 3
  • Overall success (both face and trunk): 57.9% 3
  • Quality of life improvement: 52.8% of patients achieved minimal impact on quality of life compared to 22.6% at baseline 3

Key Clinical Advantages

Trifarotene is the first fourth-generation retinoid specifically approved for both facial and truncal acne, making it particularly valuable for patients with body acne 3, 2. Its selective RAR-γ agonist mechanism provides effective treatment with a manageable side effect profile when used as directed 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.